Yuki Gosei Kogyo Co., Ltd.
Yuki Gosei Kogyo Co., Ltd. Financial Summary for the Second Quarter (Interim) of the Fiscal Year Ending March 2027
Revenue of 8,739 million yen, up 11.7% year-over-year. Interim net income was 331 million yen (up 101.0% YoY), a sharp increase. Full-year forecasts may be revised upward by 1,770 million yen in revenue, though higher raw material/fuel prices and logistics costs are impacting results.
Key Figures
- Revenue: 8,739 million yen (YoY +11.7%)
- Interim Net Income: 331 million yen (YoY +101.0%)
- Equity Ratio: 53.5%
- Treasury Stock: 308,279 shares (during the period)
- Full-year Forecasts: Revenue 17,700 million yen, Operating Income 550 million yen, Ordinary Income 500 million yen, Net Income Attributable to Owners of Parent 600 million yen (likely revised)
AI要約
Summary of Results
For the second quarter of this fiscal year, revenue increased 11.7% year-over-year to 8,739 million yen, supported by steady demand in amino acids, chemical products, and pharmaceutical-related businesses. However, persistently high raw material and energy costs and rising logistics expenses led to an operating loss and an expanded ordinary loss. Interim net income rose significantly to 331 million yen.
Outlook and Financial Position
Full-year performance forecasts may be revised upward as revenue is expected to exceed previous projections, but attention is required due to rising raw material/fuel prices and logistics costs. Numeric targets for the three-year medium-term management plan will be announced at the time of the fiscal third-quarter results for the year ending March 2027. Cash and cash equivalents increased to 1,845 million yen, operating cash flows remained solid, and financing activities were affected by movements in borrowings.
Revenue Trend
Operating Income Trend
Ordinary Income Trend
Interim Net Income Trend
Segment Revenue Breakdown
Yuki Gosei Kogyo Co., Ltd.
Company overview · Stock price · Financial data · All IR
